GB1253328A - PURIFICATION OF gamma GLOBULIN - Google Patents
PURIFICATION OF gamma GLOBULINInfo
- Publication number
- GB1253328A GB1253328A GB03046/70A GB1304670A GB1253328A GB 1253328 A GB1253328 A GB 1253328A GB 03046/70 A GB03046/70 A GB 03046/70A GB 1304670 A GB1304670 A GB 1304670A GB 1253328 A GB1253328 A GB 1253328A
- Authority
- GB
- United Kingdom
- Prior art keywords
- globulin
- solution
- recovered
- plasma
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1,253,328. Gamma-globulin purification. UPJOHN CO. 18 March, 1970 [1 April, 1969; 3 March, 1970], No. 13046/70. Heading A5B. γ-globulin is purified from blood serum or plasma by separating γ-globulin from the other proteins in the serum or plasma by treatment with acrinol and removing acrinol from the resulting aqueous solution of the γ-globulin by contacting the solution with silica gel or a mineral silicate adsorbent and separating the adsorbent from the solution. The mineral silicate may be magnesium silicate or trisilicate, native calcium-magnesium silicate, talc heulandite, stilbite, chabazite, analcite or antrolite. An insoluble portion may be separated from the plasma or serum at a pH of from 7 to 8 by adding 3.5 to 5 volumes of 0.4 to w/v acrinol aqueous solution thereto, the solution recovered is mixed at pH 7 to 8 with human erythrocyte stroma or erythrocytes and from the solution recovered y-globulin is precipitated at pH 7 to 8 by adding acetone or a C 1-6 alkanol to provide an acetone or alkanol concentration of 20 to 30% u/v and the precipitate is recovered; the precipitated y-globulin is dissolved by pH 6.5 to 7.5 in phosphate buffer and the resulting solution is treated with silica gel, the solution not adsorbed upon the silica gel is recovered, passed over diethylaminoethyl cellulose equilibrated with phosphate buffer at pH 6.7, the diethylaminoethyl cellulose is eluted with phosphate buffer at pH 6.7 and the γ-globulin is recovered from the eluate in accordance with measurements of adsorbancies at 280 mÁ. The serum or plasma treated may be that of an animal treated with lymphoid tissue of human origin, from a horse treated with human thymocytes, or of human origin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81240469A | 1969-04-01 | 1969-04-01 | |
US1622570A | 1970-03-03 | 1970-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1253328A true GB1253328A (en) | 1971-11-10 |
Family
ID=26688328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB03046/70A Expired GB1253328A (en) | 1969-04-01 | 1970-03-18 | PURIFICATION OF gamma GLOBULIN |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5515444B1 (en) |
BE (1) | BE748326A (en) |
CH (1) | CH548776A (en) |
DE (1) | DE2014957C2 (en) |
DK (1) | DK128147B (en) |
FR (1) | FR2038106B1 (en) |
GB (1) | GB1253328A (en) |
IL (1) | IL34079A (en) |
NL (1) | NL164286C (en) |
SE (1) | SE386824B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2001325A (en) * | 1977-07-19 | 1979-01-31 | Green Cross Corp | Gamma globulin preparation |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2837168A1 (en) * | 1978-08-25 | 1980-03-06 | Blutspendedienst Dt Rote Kreuz | METHOD FOR PRODUCING AN IMMUNAL GLOBULIN SOLUTION SUITABLE FOR INTRAVENOUS APPLICATION |
US4315851A (en) * | 1978-12-29 | 1982-02-16 | Kureha Kagaku Kogyo Kabushiki Kaisha | Pharmaceutical composition having antitumor activity |
ZA200504990B (en) * | 2003-01-09 | 2006-08-30 | Genentech Inc | Purification of polypeptides |
KR20150115745A (en) * | 2013-02-06 | 2015-10-14 | 에이전시 포 사이언스, 테크놀로지 앤드 리서치 | Methods for reducing aggregate content in protein preparations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3382227A (en) * | 1967-01-30 | 1968-05-07 | Pentex Inc | Blood protein fractionation employing 2-ethoxy-6, 9-diamino-acridine-lactate |
US3449316A (en) * | 1967-03-03 | 1969-06-10 | American Cyanamid Co | Process for the purification of gamma globulin employing bentonite |
-
1970
- 1970-03-16 IL IL34079A patent/IL34079A/en unknown
- 1970-03-18 GB GB03046/70A patent/GB1253328A/en not_active Expired
- 1970-03-19 DK DK140870AA patent/DK128147B/en not_active IP Right Cessation
- 1970-03-26 NL NL7004373.A patent/NL164286C/en not_active IP Right Cessation
- 1970-03-28 DE DE2014957A patent/DE2014957C2/en not_active Expired
- 1970-03-31 SE SE7004357A patent/SE386824B/en unknown
- 1970-03-31 FR FR7011475A patent/FR2038106B1/fr not_active Expired
- 1970-04-01 JP JP2709470A patent/JPS5515444B1/ja active Pending
- 1970-04-01 BE BE748326D patent/BE748326A/en not_active IP Right Cessation
- 1970-04-01 CH CH480770A patent/CH548776A/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2001325A (en) * | 1977-07-19 | 1979-01-31 | Green Cross Corp | Gamma globulin preparation |
Also Published As
Publication number | Publication date |
---|---|
NL164286B (en) | 1980-07-15 |
NL7004373A (en) | 1970-10-05 |
CH548776A (en) | 1974-05-15 |
DE2014957C2 (en) | 1982-01-28 |
FR2038106B1 (en) | 1974-02-01 |
JPS5515444B1 (en) | 1980-04-23 |
DE2014957A1 (en) | 1970-11-05 |
SE386824B (en) | 1976-08-23 |
IL34079A0 (en) | 1970-06-17 |
BE748326A (en) | 1970-10-01 |
DK128147B (en) | 1974-03-11 |
NL164286C (en) | 1980-12-15 |
FR2038106A1 (en) | 1971-01-08 |
IL34079A (en) | 1973-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Fanger et al. | Enhancement by reducing agents of the transformation of human and rabbit peripheral lymphocytes | |
Askonas | A study on globulin formation by plasma-cell neoplasm (5563) transplantable in mice | |
Allan et al. | Studies on the complement-binding site of rabbit immunoglobulin G—II. The reaction of rabbit IgG and its fragments with Clq | |
GB1495159A (en) | Process reducing the anticomplementary activity of gamma globulins | |
DE3475871D1 (en) | Process for the preparation of a composition containing a factor viii(ahf) | |
GB1253328A (en) | PURIFICATION OF gamma GLOBULIN | |
Gigli et al. | Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase. | |
Nagamatsu et al. | Purification and characterization of mouse α-lactalbumin and preparation of its antibody | |
GB779493A (en) | Process for the isolation of stable, highly purified gamma globulin preparations | |
Waldesbuhl et al. | Anticomplementary activity of γG-immunoglobulins and of their subunits | |
Seegers et al. | Isolation of platelet cofactor I from plasma and some properties of the preparation | |
Morrissey et al. | Purification of human renal calcium binding protein from necropsy specimens | |
Beato et al. | Hormone-dependent synthesis and secretion of uteroglobin in isolated rabbit uterus | |
Fishman et al. | Preparation and characterization of human intestinal alkaline phosphatase antigens | |
Gerber | Effect of chloroquine on the sulfhydryl group and the denaturation of bovine serum albumin | |
Stokes | A rapid method for the isolation of coeruloplasmin | |
US4018885A (en) | Steroid-binding globulin and process for preparing it and antibodies thereto | |
Fantl | Thiol groups of blood platelets in relation to clot retraction | |
Chechik et al. | Identification of human thymus-leukemia-associated antigen as a low-molecular-weight form of adenosine deaminase | |
DE3479032D1 (en) | Process for preparing an antihaemophilic factor concentrate | |
Bosmann | Sialic acid on the synaptosome surface and effect of concanavalin A and trypsin on synaptosome electrophoretic mobility | |
Anttinen et al. | Hydrophobic and Carbohydrate‐Recognition Chromatographies of Collagen Glucosyltransferase | |
Fearon et al. | Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation | |
US2922745A (en) | Purification of profibrinolysin | |
Cunliffe et al. | Effects of bromelain and pronase on erythrocyte membranes |